Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Development

Combination Therapy

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

Human trials have not begun, with scientists framing the mouse results as a guide for future combination studies.

Final EMBARK Results Show 40% Lower Mortality With Enzalutamide Plus Leuprolide in High-Risk Recurrent Prostate Cancer

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials